Induced chromosome deletions cause hypersociability and other features of Williams–Beuren syndrome in mice

The neurodevelopmental disorder Williams–Beuren syndrome is caused by spontaneous ∼1.5 Mb deletions comprising 25 genes on human chromosome 7q11.23. To functionally dissect the deletion and identify dosage‐sensitive genes, we created two half‐deletions of the conserved syntenic region on mouse chromosome 5G2. Proximal deletion (PD) mice lack Gtf2i to Limk1, distal deletion (DD) mice lack Limk1 to Fkbp6, and the double heterozygotes (D/P) model the complete human deletion. Gene transcript levels in brain are generally consistent with gene dosage. Increased sociability and acoustic startle response are associated with PD, and cognitive defects with DD. Both PD and D/P males are growth‐retarded, while skulls are shortened and brains are smaller in DD and D/P. Lateral ventricle (LV) volumes are reduced, and neuronal cell density in the somatosensory cortex is increased, in PD and D/P. Motor skills are most impaired in D/P. Together, these partial deletion mice replicate crucial aspects of the human disorder and serve to identify genes and gene networks contributing to the neural substrates of complex behaviours and behavioural disorders.

[1]  Feng Zhang,et al.  An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology , 2007, Journal of neural engineering.

[2]  K. Gunderson,et al.  Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region , 2007, Genetics in Medicine.

[3]  K. Schughart,et al.  Characterization and expression pattern of the frizzled gene Fzd9, the mouse homolog of FZD9 which is deleted in Williams-Beuren syndrome. , 1999, Genomics.

[4]  J. Piven,et al.  Automated apparatus for quantitation of social approach behaviors in mice , 2004, Genes, brain, and behavior.

[5]  Joan T Richtsmeier,et al.  Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. , 2002, American journal of medical genetics.

[6]  Pawel Stankiewicz,et al.  Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes , 2005, PLoS genetics.

[7]  I. Weissman,et al.  Frizzled 9 knock-out mice have abnormal B-cell development. , 2005, Blood.

[8]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[9]  J. Lupski,et al.  Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). , 2003, Human molecular genetics.

[10]  Ursula Bellugi,et al.  Reduced parietal and visual cortical activation during global processing in Williams syndrome , 2007, Developmental medicine and child neurology.

[11]  A. Peiffer,et al.  Impaired gap detection in juvenile microgyric rats. , 2004, Brain research. Developmental brain research.

[12]  N. Rinehart,et al.  Fronto-parietal and cerebellar contributions to motor dysfunction in Williams syndrome: A review and future directions , 2008, Neuroscience & Biobehavioral Reviews.

[13]  Ursula Bellugi,et al.  “Everybody in the world is my friend” hypersociability in young children with Williams syndrome , 2004, American journal of medical genetics. Part A.

[14]  M. A. Frens,et al.  Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome , 2007, Neurobiology of Disease.

[15]  Ursula Bellugi,et al.  Defining the social phenotype in Williams syndrome: A model for linking gene, the brain, and behavior , 2008, Development and Psychopathology.

[16]  Jacqueline N. Crawley,et al.  A Proposed Test Battery and Constellations of Specific Behavioral Paradigms to Investigate the Behavioral Phenotypes of Transgenic and Knockout Mice , 1997, Hormones and Behavior.

[17]  Xin Gao,et al.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21 , 2006, Nature.

[18]  M. Leppert,et al.  A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Andreas Meyer-Lindenberg,et al.  Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behaviour , 2006, Nature Reviews Neuroscience.

[20]  R. Paylor,et al.  Altered anxiety‐related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome , 2005, Genes, brain, and behavior.

[21]  U. Francke,et al.  Identification of the WBSCR9 gene, encoding a novel transcriptional regulator, in the Williams-Beuren syndrome deletion at 7q11.23 , 1998, Cytogenetic and Genome Research.

[22]  N. Carter,et al.  Germline rates of de novo meiotic deletions and duplications causing several genomic disorders , 2008, Nature Genetics.

[23]  T. Bjørnland,et al.  Dental characteristics in Williams syndrome: a clinical and radiographic evaluation , 2003, Acta odontologica Scandinavica.

[24]  D. Nelson,et al.  Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. , 2006, Human molecular genetics.

[25]  P. Fletcher,et al.  Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1‐targeted mice , 2008, Genes, brain, and behavior.

[26]  Allan L. Reiss,et al.  Relative sparing of primary auditory cortex in Williams Syndrome , 2005, Brain Research.

[27]  R. Paylor,et al.  The use of behavioral test batteries, II: Effect of test interval , 2006, Physiology & Behavior.

[28]  Webb Miller,et al.  Generation and Comparative Analysis of ∼3.3 Mb of Mouse Genomic Sequence Orthologous to the Region of Human Chromosome 7q11.23 Implicated in Williams Syndrome , 2002 .

[29]  P. Wade,et al.  WSTF–ISWI chromatin remodeling complex targets heterochromatic replication foci , 2002, The EMBO journal.

[30]  M. Bayés,et al.  Mutational mechanisms of Williams-Beuren syndrome deletions. , 2003, American journal of human genetics.

[31]  F. Ruddle,et al.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Karmiloff-Smith,et al.  Discriminating power of localized three-dimensional facial morphology. , 2005, American journal of human genetics.

[33]  J. Macdonald,et al.  Abnormal Spine Morphology and Enhanced LTP in LIMK-1 Knockout Mice , 2002, Neuron.

[34]  H. Handa,et al.  TFII‐I down‐regulates a subset of estrogen‐responsive genes through its interaction with an initiator element and estrogen receptor α , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[35]  Richard Paylor,et al.  Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains , 2002, Behavioural Brain Research.

[36]  A. Bradley,et al.  Chromosome engineering in mice , 1995, Nature.

[37]  Patrik Asp,et al.  The WSTF-SNF2h Chromatin Remodeling Complex Interacts with Several Nuclear Proteins in Transcription* , 2006, Journal of Biological Chemistry.

[38]  S. Handley,et al.  Evaluation of marble-burying behavior as a model of anxiety , 1991, Pharmacology Biochemistry and Behavior.

[39]  F. Ruddle,et al.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N. Kudryavtseva Use of the “Partition” Test in Behavioral and Pharmacological Experiments , 2003, Neuroscience and Behavioral Physiology.

[41]  Peter Hammond,et al.  GTF2IRD1 in Craniofacial Development of Humans and Mice , 2005, Science.

[42]  Kiralee M. Hayashi,et al.  Abnormal Cortical Complexity and Thickness Profiles Mapped in Williams Syndrome , 2005, The Journal of Neuroscience.

[43]  U Bellugi,et al.  Cytoarchitectonic anomalies in a genetically based disorder: Williams syndrome. , 1994, Neuroreport.

[44]  Jeffrey W Touchman,et al.  Generation and comparative analysis of approximately 3.3 Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome. , 2002, Genome research.

[45]  Ursula Bellugi,et al.  Williams syndrome: neuronal size and neuronal-packing density in primary visual cortex. , 2002, Archives of neurology.

[46]  U. Francke,et al.  Williams (Williams Beuren) Syndrome: A Distinct Neurobehavioral Disorder , 2001, Journal of child neurology.

[47]  U. Bellugi,et al.  Williams syndrome: an exploration of neurocognitive and genetic features , 2001, Clinical Neuroscience Research.

[48]  A. Peiffer,et al.  Age and experience-related improvements in gap detection in the rat. , 2004, Brain research. Developmental brain research.

[49]  U. Francke,et al.  A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome--deletion region at 7q11.23. , 2000, American journal of human genetics.

[50]  B. Pober,et al.  Williams Syndrome: An Overview of Medical, Cognitive, and Behavioral Features , 1996 .

[51]  Annette Karmiloff-Smith,et al.  In-depth analysis of spatial cognition in Williams syndrome: A critical assessment of the role of the LIMK1 gene , 2006, Neuropsychologia.

[52]  R. Fitch,et al.  Perceptual auditory gap detection deficits in male BXSB mice with cerebrocortical ectopias , 2000, Neuroreport.

[53]  Keiji Tanaka,et al.  Analysis of Knock-Out Mice to Determine the Role of HPC-1/Syntaxin 1A in Expressing Synaptic Plasticity , 2006, The Journal of Neuroscience.

[54]  T. Bjørnland,et al.  Neurocranial morphology and growth in Williams syndrome. , 2005, European journal of orthodontics.

[55]  U. Francke Williams-Beuren syndrome: genes and mechanisms. , 1999, Human molecular genetics.

[56]  Charlotte N. Henrichsen,et al.  Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. , 2006, American journal of human genetics.

[57]  S. O’Gorman,et al.  Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  G. Rosen,et al.  Developmental timeframes for induction of microgyria and rapid auditory processing deficits in the rat , 2006, Brain Research.

[59]  J. Fryns,et al.  Hyperacusis in Williams syndrome: a sample survey study. , 1997, Genetic counseling.

[60]  M. Owen,et al.  Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Snyder,et al.  Action of TFII-I Outside the Nucleus as an Inhibitor of Agonist-Induced Calcium Entry , 2006, Science.

[62]  C. Almli,et al.  Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval , 2005, Development.

[63]  Paul M. Thompson,et al.  3D pattern of brain abnormalities in Williams syndrome visualized using tensor-based morphometry , 2007, NeuroImage.

[64]  Marleen Verhoye,et al.  Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice , 2002, Nature Genetics.

[65]  U. Francke,et al.  SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice , 2008, PloS one.

[66]  A. Bradley,et al.  A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. , 1999, Nucleic acids research.

[67]  C. Broekkamp,et al.  Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. , 1986, European journal of pharmacology.